MRI in Patients With Inflammatory Bowel Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02255019|
Recruitment Status : Completed
First Posted : October 2, 2014
Last Update Posted : October 2, 2014
The aim of this study is to find an optimal magnetic resonance imaging (MRI) method to examine patients with inflammatory bowel disease (IBD). Patients should furthermore avoid being exposed to unnecessary X-rays and invasive examination.
It is the investigators expectation that this study will benefit to future patients, as they will be offered MRI as the first choice. Hereby, the patients avoid the risks and discomfort associated with x-ray examinations. The aim is that patients with IBD achieve better and earlier treatment and if this is achieved it both benefits patient and public health. An earlier treatment leads to fewer hospitalizations and thereby saving the community money.
The investigators hope is that the investigators study will show that MRI is one of the best tool to examine patients with IBD and that this in future leads MRI to be the first choice in contrary to all examinations with x-ray exposer, unless there is any contraindication to MRI.
|Condition or disease|
|Inflammatory Bowel Disease|
|Study Type :||Observational|
|Actual Enrollment :||125 participants|
|Official Title:||MRI in Patients With Inflammatory Bowel Disease|
|Study Start Date :||May 2011|
|Actual Primary Completion Date :||June 2013|
|Actual Study Completion Date :||June 2013|
IBD, CD, UC
All patients should either have a known IBD diagnose or suspect of having IBD.
- Inflammation changes in gastrointestinal tract in MRI. [ Time Frame: 1 day ]Observe the inflammatory changes in bowel.
- evaluate MRI using faecal calprotectin (fC) as a reference standard. [ Time Frame: 1-3 days ]MRI is evaluated and fC is received about 3 day after MRI.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02255019
|Department of Diagnostic Radiology|
|Herlev, Denmark, 2730|
|Principal Investigator:||Kayalvily J. Nielsen, MD||Copenhagen University Hospital at Herlev|